DOI 10.3760/cma.j.cn112137-20250827-02199
[Correlation analysis of serum transforming growth factor-β stimulated clone 22 domain family member 4 with type 2 diabetes mellitus combined with metabolic associated fatty liver disease].
Аннотация
Objective
To explore the correlation between serum transforming growth factor-β stimulated clone 22 domain family member 4 (TSC22D4) and type 2 diabetes mellitus (T2DM) combined with metabolic associated fatty liver disease (MAFLD).
Methods
Prospectively, 257 patients with T2DM who were hospitalized at Gansu Provincial Hospital from April 2024 to April 2025 were included in this study, comprising 168 males and 89 females, with the age of [M(Q1, Q3)] 53(47, 58) years. Based on their disease status, the patients were divided into the simple T2DM group (n=127) and the T2DM+MAFLD group (n=130). Additionally, healthy individuals from the physical examination center during the same period were enrolled as the normal control group (n=132), including 80 males and 52 females, with the age of 51(47, 57) years. Clinical data were collected, and differences in clinical indicators among the three groups were compared. Spearman correlation analysis was employed to examine the correlations between TSC22D4 and metabolic and inflammatory indicators. A multivariate logistic regression model was employed to analyze the influencing factors of T2DM complicated with MAFLD.
Results
The body mass index (BMI), visceral fat area (VFA), fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance index (HOMA-IR), glycated hemoglobin (HbA1c), TSC22D4, interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hs-CRP) levels were all higher in both the simple T2DM group and the T2DM+MAFLD group compared to the normal control group. Moreover, all these indicators were significantly elevated in the T2DM+MAFLD group compared to the simple T2DM group (all P<0.05). Conversely, high-density lipoprotein cholesterol levels were lower in both the simple T2DM group and the T2DM+MAFLD group compared to the normal control group, with the T2DM+MAFLD group exhibiting even lower levels than the simple T2DM group (all P<0.05). Among the 257 T2DM patients, Spearman correlation analysis revealed that TSC22D4 was positively correlated with BMI, VFA, FBG, FINS, HOMA-IR, HbA1c, triglycerides, total cholesterol, low-density lipoprotein cholesterol, IL-6, and hs-CRP (all P<0.05). The results of the multivariate logistic regression model analysis revealed that elevated BMI (OR=1.286, 95%CI:1.128-1.465), longer duration of diabetes (OR=1.098, 95%CI:1.036-1.163), and elevated TSC22D4 levels (OR=1.031, 95%CI:1.021-1.040) were associated factors contributing to the increased risk of T2DM complicated with MAFLD.
Conclusions
Elevated TSC22D4 is a relevant factor contributing to the increased risk of developing T2DM complicated with MAFLD. Serum TSC22D4 may contribute to the development and progression of MAFLD in T2DM patients by exacerbating insulin resistance and inflammatory responses.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.